$SLS News Article - SELLAS Life Sciences' Highly Selective CDK9 Inhibitor, GFH009, Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Model of Neuroendocrine Prostate Cancer Cell Line
https://marketwirenews.com/news-releases/sell...40795.html